Hennig

Hennig Arzneimittel is an independent, family-owned German pharmaceutical company headquartered in Flörsheim am Main. Founded in 1898, the company has established itself as a specialist in the treatment of vertigo and balance disorders, most notably through its market-leading product Arlevert. Beyond its focus on vertigo, Hennig develops and manufactures a wide range of generic and proprietary medicines covering therapeutic areas such as cardiovascular disease, neurology, and psychiatry. The company operates its own GMP-certified manufacturing facilities, ensuring high quality standards for its diverse product portfolio. Their products are distributed primarily in the DACH region and through international partners in over 30 countries. Hennig remains committed to research and development, particularly in optimizing drug delivery and combination therapies for CNS-related conditions.